GSK plc
GSK
#260
Rank
HK$731.07 B
Marketcap
HK$364.89
Share price
-0.09%
Change (1 day)
7.94%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): HK$24.97

According to GSK plc's latest financial reports the company's current EPS (TTM) is HK$25.09. In 2025 the company made an earnings per share (EPS) of HK$29.57 an increase over its 2024 EPS that were of HK$12.51.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$24.97-15.57%
2025HK$29.57136.36%
2024HK$12.51-47.35%
2023HK$23.76-64.2%
2022HK$66.37182.29%
2021HK$23.51-18.07%
2020HK$28.7022.34%
2019HK$23.4623.9%
2018HK$18.93140.61%
2017HK$7.8764.45%
2016HK$4.79-90.61%
2015HK$50.94178.12%
2014HK$18.32-48.11%
2013HK$35.3022.68%
2012HK$28.77-11.31%
2011HK$32.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$52.26 108.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-76.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.93-40.49%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$9.93-60.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.42 108.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.94-80.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
-HK$2.51-110.01%๐Ÿ‡บ๐Ÿ‡ธ USA